期刊文献+

RNAi沉默Sp3基因对肝癌HepG2细胞增殖的影响 被引量:4

RNAi-mediated down-regulation of Sp3 gene expression inhibits proliferation of HepG2 cells
暂未订购
导出
摘要 目的:采用基因沉默和慢病毒转染技术,沉默人肝癌细胞HepG2中特异蛋白3(specificity protein 3,Sp3)的表达,观察沉默Sp3基因后的肝细胞的增殖能力变化.方法:采用Sp3-siRNA慢病毒转染人肝癌细胞HepG2,通过免疫印迹法和PCR技术检测Sp3的表达以验证转染效果,通过MTT检测细胞生长曲线和流式细胞技术测定细胞周期.结果:Western blot实验表明,实验组的Sp3表达量明显少于空白组和阴性对照组(0.37±0.08 vs 0.83±0.17,0.66±0.13,F=8.442,均P<0.05).RT-PCR也得到相同的结果(0.47±0.05 vs 0.74±0.08,0.70±0.16,F=7.322,均P<0.05).MTT实验结果显示,与空白对照和阴性对照组相比,实验组细胞在48、72和96h时的增殖明显受到抑制(0.28±0.18 vs 0.34±0.19,0.35±0.07,F=3.888;0.57±0.11 vs 0.84±0.05,0.74±0.08,F=12.721;0.72±18.1 vs 0.98±0.05,0.93±0.9,F=6.342,均P<0.05).流式细胞术结果显示实验组细胞主要分布在G1期.结论:RNAi沉默Sp3基因导致人肝癌HepG2细胞体外增殖能力下降. AIM:To investigate the effect of RNA interference(RNAi)-mediated gene silencing of specif icity protein 3(Sp3) on the proliferation of human hepatocellular carcinoma HepG2 cells.METHODS:HepG2 cells were infected with a lentivirus expressing Sp3-siRNA,and the ex-pression of Sp3 mRNA and protein was determined by semi-quantitative reverse transcription polymerase chain reaction(RT-PCR),and Western blot and immunohistochemistry.Cell growth was evaluated by methyl thiazolyl tetrazolium(MTT) assay,and cell cycle progression was analyzed by fow cytometry.RESULTS:Compared to control cells,the expression levels of Sp3 mRNA and protein were signif icantly lower in HepG2 cells transfected with the Sp3-siRNA(mRNA:0.47 ± 0.05 vs 0.74 ± 0.08,0.70 ± 0.16,F = 7.322,all P 0.05;protein:0.37 ± 0.08 vs 0.83 ± 0.17,0.66 ± 0.13,F = 8.442,all P 0.05).MTT assay showed that the growth of cells transfected with the Sp3-siRNA was slower at 48,72 and 96 h(0.28 ± 0.18 vs 0.34 ± 0.19,0.35 ± 0.07,F = 3.888;0.57 ± 0.11 vs 0.84 ± 0.05,0.74 ± 0.08,F=12.721;0.72±18.1vs0.98±0.05,0.93 ± 0.9,F = 6.342,all P 0.05).Flow cytometry analysis showed that the percentage of cells in G1 phase increased in cells transfected with the Sp3-siRNA.CONCLUSION:Sp3 may play an important role in the growth of human hepatic cancer cells,and RNAi-induced Sp3 down-regulation could inhibit the growth of HepG2 cells in vitro.
出处 《世界华人消化杂志》 CAS 北大核心 2012年第27期2595-2600,共6页 World Chinese Journal of Digestology
基金 广西壮族自治区卫生厅自筹经费科研基金资助项目 No.Z2012052 广西壮族自治区"新世纪十百千人才工程"专项基金资助项目 No.2007214~~
关键词 肝细胞癌 特异蛋白3 RNA干扰 WESTERN BLOT RT-PCR 流式细胞术 Hepatocellular carcinoma Specif icity protein 3 RNA Interference Western blot RT-PCR Flow cytometry
  • 相关文献

参考文献26

  • 1Li L, Davie JR. The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 2010; 192: 275-283.
  • 2Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, Tang H, Xiong Q, Wang B, Li XC, Xie K. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 2001; 61: 4143-4154.
  • 3Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M. Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 2000; 60: 1546-1551.
  • 4Chiefari E, Brunetti A, Arturi F, Bidart JM, Russo D, Schlumberger M, Filetti S. Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer 2002; 2: 35.
  • 5Kingsley C, Winoto A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol 1992; 12: 4251-4261.
  • 6Kennett SB, Udvadia AJ, Horowitz JM. Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res 1997; 25: 3110-3117.
  • 7Sapetschnig A, Koch F, Rischitor G, Mennenga T, Suske G. Complexity of translationally controlled transcription factor Sp3 isoform expression. J Biol Chem 2004; 279: 42095-42105.
  • 8Yu B, Datta PK, Bagchi S. Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res 2003; 31: 5368-5376.
  • 9Sowa Y, Orita T, Minamikawa-Hiranabe S, Mizuno T, Nomura H, Sakai T. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res 1999; 59: 4266-4270.
  • 10Gartel AL, Goufman E, Najmabadi F, Tyner AL. Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line. Oncogene 2000; 19: 5182-5188.

二级参考文献18

共引文献7

同被引文献69

  • 1Norihiro Imai,Masatoshi Ishigami,Yoji Ishizu,Teiji Kuzuya,Takashi Honda,Kazuhiko Hayashi,Yoshiki Hirooka,Hidemi Goto.Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques[J].World Journal of Hepatology,2014,6(12):844-850. 被引量:26
  • 2吴军峰,童坦君,张宗玉.人成纤维细胞转录因子Sp1Sp3对p16^(INK4a)基因的调控[J].中国生物化学与分子生物学报,2005,21(1):88-93. 被引量:4
  • 3朱明华,倪灿荣,祝峙,李芳梅,张顺民.原发性肝细胞癌中5种细胞周期蛋白的表达及其临床意义[J].中华病理学杂志,2003,32(5):440-443. 被引量:7
  • 4邹向阳,李连宏.细胞周期调控与肿瘤[J].国际遗传学杂志,2006,29(1):70-73. 被引量:77
  • 5ChintharIapalIi S, Papineni S, Ramaiah SK, Safe S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 2007; 67: 2816-2823 [PMID: 17363604 DOI: 10.1158/0008-5472.CAN-06-3735].
  • 6Jutooru 1, Chadalapaka G, Sreevalsan S, Lei P, Barhoumi R, Burghardt R, Safe S. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Exp Cell Res 2010; 316: 2174-2188 [PMID: 20435036 DOI: 10.1016/j.yexcr.2010.04.027].
  • 7Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 2011; 11: 371 [PMID: 21864401].
  • 8Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 2007; 67: 11001-11011 [PMID: 18006846 DOI: 10.1158/0008-5472.CAN-07-2416].
  • 9Papineni S, Chintharlapalli S, Abdelrahim M, Lee SO, Burghardt R, Abudayyeh A, Baker C, Herrera L, Safe S. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. Carcinogenesis 2009; 30: 1193-1201 [pMID: 19406933 DOI: 10.1093/carcin/bgp092].
  • 10Gao Y, Jia Z, Kong X, Li Q, Chang DZ, Wei D, Le X, Suyun H, Huang S, Wang L, Xie K. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. Cancer Res 2011; 71: 5182-5193 [PMID: 21673052 DOI: 10.1158/0008-5472.CAN-10-2016].

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部